{"title":"Telomere Maintenance-Related Genes are Essential for Prognosis in Breast Cancer.","authors":"Wei Huang, Wei Wang, Tuo-Zhou Dong","doi":"10.2147/BCTT.S506783","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Telomere maintenance mechanism significantly impacts the metastasis, progression, and survival of breast cancer (BC) patients. This study aimed to investigate the role of telomere maintenance-related genes (TMRGs) in BC prognosis and to construct a related prognostic model.</p><p><strong>Methods: </strong>Differentially expressed genes were identified from the TCGA-BC cohort, and functional enrichment analysis was conducted. TMRGs were sourced from the literature and intersected with DEGs. Candidate genes were selected using machine learning algorithms, including Lasso Cox, Random Forest, and XGBoost. Multivariate Cox regression analysis was conducted to construct a prognostic model and identify hub genes. Subsequent analyses included survival analysis, gene set enrichment analysis (GSEA), immune infiltration analysis, and drug sensitivity analysis of the hub genes. Finally, in vitro experiments were conducted to validate the expression of the hub genes.</p><p><strong>Results: </strong>A total of 1329 differentially expressed TMRGs were analyzed, with 128 significantly associated with overall survival. Machine learning identified 7 prognosis-related TMRGs: MECP2, PCMT1, PFKL, PTMA, TAGLN2, TRMT5, and XRCC4. These genes were used to construct a prognostic model, with MECP2, PCMT1, PFKL, TAGLN2, and XRCC4 as harmful factors, while PTMA and TRMT5 were protective. The model demonstrated a significant prognostic value (AUC: 0.81, 0.72, 0.69 for 1-, 3-, and 5-year, respectively). Survival analysis confirmed the prognostic relevance of these genes, and GSEA highlighted their roles in oxidative phosphorylation, glycolysis, and PI3K/AKT/mTOR signaling.</p><p><strong>Conclusion: </strong>The study identified 7 key TMRGs with significant prognostic value in BC. The constructed model effectively stratifies patient risk, providing a foundation for targeted therapies and personalized treatment strategies.</p>","PeriodicalId":9106,"journal":{"name":"Breast Cancer : Targets and Therapy","volume":"17 ","pages":"225-239"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869761/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer : Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/BCTT.S506783","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Telomere maintenance mechanism significantly impacts the metastasis, progression, and survival of breast cancer (BC) patients. This study aimed to investigate the role of telomere maintenance-related genes (TMRGs) in BC prognosis and to construct a related prognostic model.
Methods: Differentially expressed genes were identified from the TCGA-BC cohort, and functional enrichment analysis was conducted. TMRGs were sourced from the literature and intersected with DEGs. Candidate genes were selected using machine learning algorithms, including Lasso Cox, Random Forest, and XGBoost. Multivariate Cox regression analysis was conducted to construct a prognostic model and identify hub genes. Subsequent analyses included survival analysis, gene set enrichment analysis (GSEA), immune infiltration analysis, and drug sensitivity analysis of the hub genes. Finally, in vitro experiments were conducted to validate the expression of the hub genes.
Results: A total of 1329 differentially expressed TMRGs were analyzed, with 128 significantly associated with overall survival. Machine learning identified 7 prognosis-related TMRGs: MECP2, PCMT1, PFKL, PTMA, TAGLN2, TRMT5, and XRCC4. These genes were used to construct a prognostic model, with MECP2, PCMT1, PFKL, TAGLN2, and XRCC4 as harmful factors, while PTMA and TRMT5 were protective. The model demonstrated a significant prognostic value (AUC: 0.81, 0.72, 0.69 for 1-, 3-, and 5-year, respectively). Survival analysis confirmed the prognostic relevance of these genes, and GSEA highlighted their roles in oxidative phosphorylation, glycolysis, and PI3K/AKT/mTOR signaling.
Conclusion: The study identified 7 key TMRGs with significant prognostic value in BC. The constructed model effectively stratifies patient risk, providing a foundation for targeted therapies and personalized treatment strategies.
目的:端粒维持机制显著影响乳腺癌(BC)患者的转移、进展和生存。本研究旨在探讨端粒维持相关基因(TMRGs)在BC预后中的作用,并建立相关预后模型。方法:从TCGA-BC队列中鉴定差异表达基因,并进行功能富集分析。tmrg来源于文献,并与deg交叉。使用机器学习算法选择候选基因,包括Lasso Cox, Random Forest和XGBoost。多因素Cox回归分析构建预后模型并鉴定枢纽基因。随后的分析包括生存分析、基因集富集分析(GSEA)、免疫浸润分析和中心基因的药物敏感性分析。最后,通过体外实验验证枢纽基因的表达。结果:共分析了1329个差异表达的TMRGs,其中128个与总生存期显著相关。机器学习确定了7种与预后相关的TMRGs: MECP2、PCMT1、PFKL、PTMA、TAGLN2、TRMT5和XRCC4。利用这些基因构建预后模型,其中MECP2、PCMT1、PFKL、TAGLN2和XRCC4为有害因素,PTMA和TRMT5为保护因素。该模型具有显著的预后价值(1年、3年和5年的AUC分别为0.81、0.72、0.69)。生存分析证实了这些基因的预后相关性,GSEA强调了它们在氧化磷酸化、糖酵解和PI3K/AKT/mTOR信号传导中的作用。结论:该研究确定了7个在BC中具有重要预后价值的关键TMRGs。构建的模型有效地对患者风险进行分层,为靶向治疗和个性化治疗策略提供基础。